Atrial Fibrosis: an Obligatory Component of Arrhythmia Mechanisms in Atrial Fibrillation?

Overview

Journal J Geriatr Cardiol

Specialty Geriatrics

Date 2017 Jun 9

PMID 28592960

Authors

Pyotr G Platonov

Affiliations

Soon will be listed here.

References

Kottkamp H . Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol. 2012; 23(7):797-9. DOI: 10.1111/j.1540-8167.2012.02341.x. View

Li D, Fareh S, Leung T, Nattel S . Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999; 100(1):87-95. DOI: 10.1161/01.cir.100.1.87. View

Gramley F, Lorenzen J, Knackstedt C, Rana O, Saygili E, Frechen D . Age-related atrial fibrosis. Age (Dordr). 2009; 31(1):27-38. PMC: 2645993. DOI: 10.1007/s11357-008-9077-9. View

Miragoli M, Glukhov A . Atrial Fibrillation and Fibrosis: Beyond the Cardiomyocyte Centric View. Biomed Res Int. 2015; 2015:798768. PMC: 4502285. DOI: 10.1155/2015/798768. View

Frustaci A, Caldarulo M, Buffon A, Bellocci F, Fenici R, Melina D . Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest. 1991; 100(2):303-6. DOI: 10.1378/chest.100.2.303. View

Wijffels M, Kirchhof C, Dorland R, Allessie M . Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995; 92(7):1954-68. DOI: 10.1161/01.cir.92.7.1954. View

Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H . Candesartan in the prevention of relapsing atrial fibrillation. Int J Cardiol. 2006; 120(1):85-91. DOI: 10.1016/j.ijcard.2006.08.086. View

de Jong S, van Veen T, van Rijen H, de Bakker J . Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol. 2010; 57(6):630-8. DOI: 10.1097/FJC.0b013e318207a35f. View

Shinagawa K, Shi Y, Tardif J, Leung T, Nattel S . Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation. 2002; 105(22):2672-8. DOI: 10.1161/01.cir.0000016826.62813.f5. View

10.

Tveit A, Grundtvig M, Gundersen T, Vanberg P, Semb A, Holt E . Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol. 2004; 93(6):780-2. DOI: 10.1016/j.amjcard.2003.12.009. View

11.

Schmieder R, Kjeldsen S, Julius S, McInnes G, Zanchetti A, Hua T . Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008; 26(3):403-11. DOI: 10.1097/HJH.0b013e3282f35c67. View

12.

Begg G, Holden A, Lip G, Plein S, Tayebjee M . Assessment of atrial fibrosis for the rhythm control of atrial fibrillation. Int J Cardiol. 2016; 220:155-61. DOI: 10.1016/j.ijcard.2016.06.144. View

13.

Avitall B, Bi J, Mykytsey A, Chicos A . Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control. Heart Rhythm. 2008; 5(6):839-45. DOI: 10.1016/j.hrthm.2008.02.042. View

14.

Smith J, Newton-Cheh C, Almgren P, Struck J, Morgenthaler N, Bergmann A . Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol. 2010; 56(21):1712-9. PMC: 3005324. DOI: 10.1016/j.jacc.2010.05.049. View

15.

Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo M, Maseri A . Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997; 96(4):1180-4. DOI: 10.1161/01.cir.96.4.1180. View

16.

Shiroshita-Takeshita A, Brundel B, Burstein B, Leung T, Mitamura H, Ogawa S . Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res. 2007; 74(1):75-84. DOI: 10.1016/j.cardiores.2007.01.002. View

17.

Caldwell J, Contractor H, Petkar S, Ali R, Clarke B, Garratt C . Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace. 2009; 11(10):1295-300. DOI: 10.1093/europace/eup201. View

18.

Schoonderwoerd B, Ausma J, Crijns H, Van Veldhuisen D, Blaauw E, Van Gelder I . Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate. J Cardiovasc Electrophysiol. 2004; 15(10):1167-74. DOI: 10.1046/j.1540-8167.2004.03693.x. View

19.

Platonov P, Mitrofanova L, Orshanskaya V, Ho S . Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011; 58(21):2225-32. DOI: 10.1016/j.jacc.2011.05.061. View

20.

Xie Y, Garfinkel A, Camelliti P, Kohl P, Weiss J, Qu Z . Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: A computational study. Heart Rhythm. 2009; 6(11):1641-9. PMC: 3013501. DOI: 10.1016/j.hrthm.2009.08.003. View